Viewing Study NCT05995405


Ignite Creation Date: 2025-12-25 @ 3:16 AM
Ignite Modification Date: 2025-12-26 @ 1:55 AM
Study NCT ID: NCT05995405
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-10-01
First Post: 2023-07-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH
Sponsor: Grace Therapeutics Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module